Indications for and adverse effects of red-cell transfusion

Jeffrey L. Carson; Darrell J. Triulzi; Paul M. Ness

doi:10.1056/NEJMra1612789

Indications for and adverse effects of red-cell transfusion

Jeffrey L. Carson, Darrell J. Triulzi, Paul M. Ness

Robert Wood Johnson Medical School (RWJMS), Medicine, Division of General Internal Medicine

Research output: Contribution to journal › Review article › peer-review

191 Scopus citations

Original language	English (US)
Pages (from-to)	1261-1272
Number of pages	12
Journal	New England Journal of Medicine
Volume	377
Issue number	13
DOIs	https://doi.org/10.1056/NEJMra1612789
State	Published - Sep 28 2017

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1056/NEJMra1612789

Cite this

@article{465c1ec960064fd6a74d445f3708fe8d,

title = "Indications for and adverse effects of red-cell transfusion",

author = "Carson, {Jeffrey L.} and Triulzi, {Darrell J.} and Ness, {Paul M.}",

note = "Funding Information: Dr. Carson reports receiving grant support from Terumo BCT; Dr. Triulzi, receiving advisory board fees from Carmell and Fresenius Kabi and fees for serving on a data and safety monitoring board from Cerus Corporation; Dr. Ness, receiving fees for serving as scientific advisor from Terumo BCT and New Health Sciences. No other potential conflict of interest relevant to this article was reported.",

year = "2017",

month = sep,

day = "28",

doi = "10.1056/NEJMra1612789",

language = "English (US)",

volume = "377",

pages = "1261--1272",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "13",

}

TY - JOUR

T1 - Indications for and adverse effects of red-cell transfusion

AU - Carson, Jeffrey L.

AU - Triulzi, Darrell J.

AU - Ness, Paul M.

N1 - Funding Information: Dr. Carson reports receiving grant support from Terumo BCT; Dr. Triulzi, receiving advisory board fees from Carmell and Fresenius Kabi and fees for serving on a data and safety monitoring board from Cerus Corporation; Dr. Ness, receiving fees for serving as scientific advisor from Terumo BCT and New Health Sciences. No other potential conflict of interest relevant to this article was reported.

PY - 2017/9/28

Y1 - 2017/9/28

UR - http://www.scopus.com/inward/record.url?scp=85030649324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030649324&partnerID=8YFLogxK

U2 - 10.1056/NEJMra1612789

DO - 10.1056/NEJMra1612789

M3 - Review article

C2 - 28953438

AN - SCOPUS:85030649324

SN - 0028-4793

VL - 377

SP - 1261

EP - 1272

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 13

ER -

Indications for and adverse effects of red-cell transfusion

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this